1. Home
  2. SCNX vs COEP Comparison

SCNX vs COEP Comparison

Compare SCNX & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCNX
  • COEP
  • Stock Information
  • Founded
  • SCNX 2010
  • COEP 2017
  • Country
  • SCNX United States
  • COEP United States
  • Employees
  • SCNX N/A
  • COEP N/A
  • Industry
  • SCNX Other Pharmaceuticals
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SCNX Health Care
  • COEP Health Care
  • Exchange
  • SCNX Nasdaq
  • COEP Nasdaq
  • Market Cap
  • SCNX 33.6M
  • COEP 32.4M
  • IPO Year
  • SCNX 2020
  • COEP N/A
  • Fundamental
  • Price
  • SCNX $3.17
  • COEP $12.34
  • Analyst Decision
  • SCNX
  • COEP
  • Analyst Count
  • SCNX 0
  • COEP 0
  • Target Price
  • SCNX N/A
  • COEP N/A
  • AVG Volume (30 Days)
  • SCNX 12.0K
  • COEP 114.7K
  • Earning Date
  • SCNX 02-25-2025
  • COEP 03-25-2025
  • Dividend Yield
  • SCNX N/A
  • COEP N/A
  • EPS Growth
  • SCNX N/A
  • COEP N/A
  • EPS
  • SCNX 3.55
  • COEP N/A
  • Revenue
  • SCNX N/A
  • COEP N/A
  • Revenue This Year
  • SCNX $1,085.75
  • COEP N/A
  • Revenue Next Year
  • SCNX N/A
  • COEP N/A
  • P/E Ratio
  • SCNX $1.31
  • COEP N/A
  • Revenue Growth
  • SCNX 166.67
  • COEP N/A
  • 52 Week Low
  • SCNX $3.01
  • COEP $2.31
  • 52 Week High
  • SCNX $44.56
  • COEP $13.70
  • Technical
  • Relative Strength Index (RSI)
  • SCNX N/A
  • COEP 62.70
  • Support Level
  • SCNX N/A
  • COEP $8.65
  • Resistance Level
  • SCNX N/A
  • COEP $13.70
  • Average True Range (ATR)
  • SCNX 0.00
  • COEP 1.76
  • MACD
  • SCNX 0.00
  • COEP -0.18
  • Stochastic Oscillator
  • SCNX 0.00
  • COEP 72.97

About SCNX Scienture Holdings Inc. Common Stock

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Share on Social Networks: